Trial NCT00647972

View at ClinicalTrials.gov 
Org. Study IDs: OLAN-02136

Last trial update was posted on 2009-11-23

MeSH Interventions

Olanzapine

MeSH Conditions


Other Conditions

Healthy

Stopping Reasons

during Period 1 due to numerous orthostatic AEs that occurred. Subsequently, RLD was reduced to 5 mg due to safety concerns.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID